Inova Loudoun Hospital issued the following announcement on Aug. 31
Morgan Turner, MS, CGC, is a Virginia-licensed and nationally board-certified, cancer-specialized genetic counselor at Inova Schar Cancer Institute. She joined Inova in June 2018.
Many patients are surprised to learn that the majority of people who are diagnosed with a cancer do not have a genetic (or inherited) cause for their cancer. Indeed, it is a minority of individuals and families who are born with an inherited “predisposition,” or higher than average risk, of developing cancer due to a genetic “mutation,” or error.
In the nearly three decades since the discovery of BRCA1 and BRCA2, genetic testing for inherited cancer risk is more comprehensive and more popular than ever before. In recent years, a growing number of clinical (or medical-grade) and direct-to-consumer (DTC) genetic testing laboratory options have become available, with a wide range of quality, cost and access points that can vary dramatically from one laboratory option to another. With so many options for accessing genetic testing to learn more about your risk of cancer, what are some of the factors that are important to consider?
Original source can be found here.
Alerts Sign-up